MedPacto, Inc.
Develops first-in-class therapies for oncology and autoimmune diseases.
235980 | KO
Overview
Corporate Details
- ISIN(s):
- KR7235980000
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 명달로 92, 보림빌딩, 서초구
- Website:
- http://www.medpacto.com/eng/
- Sector:
- Manufacturing
Description
MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of first-in-class therapies. The company leverages a biomarker-driven and genome-based platform to create personalized treatments, aiming to advance precision medicine. Its primary therapeutic areas include oncology and autoimmune diseases, with pipeline expansion into metabolic and bone joint disorders. MedPacto's research focuses on novel mechanisms, such as modulating the tumor microenvironment, to address incurable diseases and overcome the limitations of existing treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-11-21 00:00 |
투자판단관련주요경영사항(재발성, 불응성 또는 진행성 골육종 환자 대상 백토서팁 단독 요법 제1/2상 임상시험계획(IND) 한국 식약처(MFDS…
|
Korean | 9.0 KB | ||
| 2022-11-16 00:00 |
기타경영사항(자율공시)(특허권 취득)
|
Korean | 6.1 KB | ||
| 2022-11-11 00:00 |
분기보고서 (2022.09)
|
Korean | 1.2 MB | ||
| 2022-09-29 00:00 |
주식매수선택권부여에관한신고
|
Korean | 13.0 KB | ||
| 2022-09-19 00:00 |
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2022-09-01 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2022-08-12 00:00 |
반기보고서 (2022.06)
|
Korean | 1.2 MB | ||
| 2022-08-08 00:00 |
투자판단관련주요경영사항(재발 난치성/진행성 골육종 환자 대상 백토서팁 단독 요법 제1/2상 임상시험계획(IND)미국 식품의약국(FDA) 승인)
|
Korean | 10.0 KB | ||
| 2022-07-11 00:00 |
투자판단관련주요경영사항(재발 난치성/진행성 골육종 환자 대상 백토서팁 단독 요법 제1/2상 임상시험계획(IND) 미국 식품의약국(FDA) 신청)
|
Korean | 9.4 KB | ||
| 2022-05-25 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.4 KB | ||
| 2022-05-24 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2022-05-23 00:00 |
투자판단관련주요경영사항(진행성 데스모이드 종양(공격성 섬유종증)에서 이매티닙 단독요법 대비 백토서팁 및 이매티닙 병용요법 비교시험 (MP-VA…
|
Korean | 9.7 KB | ||
| 2022-05-13 00:00 |
분기보고서 (2022.03)
|
Korean | 1.1 MB | ||
| 2022-04-28 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 61.5 KB | ||
| 2022-04-21 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB |
Automate Your Workflow. Get a real-time feed of all MedPacto, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MedPacto, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MedPacto, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
